Skip to main content
Lime Chemicals Ltd. logo

Lime Chemicals Ltd. — Investor Relations & Filings

Ticker · 507759 ISIN · INE891G01011 BSE.NS Manufacturing
Filings indexed 274 across all filing types
Latest filing 2024-04-15 Regulatory Filings
Country IN India
Listing BSE.NS 507759

About Lime Chemicals Ltd.

https://www.limechem.com/

Lime Chemicals Ltd. specializes in the production of high-quality Calcium Carbonate, specifically focusing on Precipitated Calcium Carbonate (PCC) and Activated Calcium Carbonate. The company operates manufacturing facilities that utilize advanced carbonation processes to ensure high purity and specific particle size distributions. Its product portfolio serves a wide range of industrial applications, including the formulation of oral care products like toothpaste, pharmaceutical excipients, and fillers for the polymer, rubber, and paper sectors. The company provides various grades tailored to meet stringent technical specifications for opacity, brightness, and chemical stability. By maintaining a focus on research and development, the firm supports specialized requirements in the plastics and coatings industries, positioning itself as a key supplier of mineral-based functional additives.

Recent filings

Filing Released Lang Actions
In compliance with 74(5) of SEBI (DP) Regulations, we submit the certificate for the quarter ended on 31st March 2024.
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March 2024. It is a compliance certificate from the Registrar and Transfer Agent confirming dematerialization and listing status of securities. The document is short (2783 characters) and primarily serves as a certification letter rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or detailed report data. It is a regulatory compliance filing and certification rather than a report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS).
2024-04-15 English
Submitting herewith the compliance certificate under Regulation 7(3) of SEBI (LODR) Regulations for the year ended on 31st March 2024.
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate submitted under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2024. It is signed by the Company Secretary and the Share Transfer Agent, certifying compliance with share transfer activities. The document is short (3024 characters) and serves as a certification rather than a full financial or management report. It does not contain financial statements or detailed analysis. According to the Certification Rule, such officer certifications or compliance certificates should be classified as Regulatory Filings (RNS).
2024-04-11 English
As per BSE email dated April 06, 2024, submitting the AGM outcome with the concluding time.
AGM Information Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) reporting on the proceedings of the 53rd Annual General Meeting (AGM) held on September 30, 2023. It lists the agenda items transacted at the AGM, including adoption of audited financial statements, appointment and re-appointment of directors, appointment of auditors, ratification of remuneration, and approval of related party transactions. It also mentions the provision of remote e-voting and physical voting facilities. The document explicitly states it is about the proceedings of the AGM and does not contain the full financial statements or detailed financial data itself. The document length is 2750 characters, which is relatively short and consistent with an announcement or summary of AGM proceedings rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or summaries of the meeting proceedings.
2024-04-06 English
In compliance with code of conduct to regulate, monitor and report trading by Designated Persons for trading in Company''s Shares, the Trading Window will be closed from 01st April 2024 ....
Regulatory Filings Classification · 95% confidence The document is a letter from the company to the stock exchange announcing the closure of the trading window in accordance with the Code of Conduct related to trading by designated persons. It mentions the upcoming declaration of audited financial results for the quarter ending March 31, 2024, but does not contain any financial data or the results themselves. The document is short (1163 characters) and serves as a notification rather than a report. Therefore, it is an announcement related to trading restrictions ahead of financial results, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2024-03-28 English
We submit the reply to the clarification sought on price movement of the shares of the Company as per attachment.
Regulatory Filings
2024-02-28 English
The letter informing the loss of share certificate received by the Registrar & Transfer Agent is attached herewith.
Regulatory Filings
2024-02-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.